UBS Recommends SK Hynix ADRs Ahead of Major Nasdaq Listing
UBS has issued a recommendation for investors to acquire SK Hynix’s upcoming American Depositary Receipts (ADRs) on Nasdaq and to divest from the company’s Korean-listed shares. This rotation trade is centered around one of the largest ADR launches in history, with SK Hynix, the world’s second-largest memory chipmaker, set to begin trading on July 10, 2026. The offering could raise up to $29 billion through the issuance of 17.79 million shares, with each ADR representing one-tenth of a common share. This move provides US investors a direct pathway to a company that plays a vital role in NVIDIA’s AI infrastructure.
UBS has maintained a Buy rating on SK Hynix and recently increased its price target to ₩3.2 million, approximately $2,091 per share. This adjustment follows an 8% decline in SK Hynix stock, which UBS interpreted as a buying opportunity rather than a warning sign. The bank estimates that the ADR listing could attract around $3.5 billion in passive inflows due to index inclusion, which would automatically draw investments from funds that track benchmarks.
For Your Trading Desk
Sponsor Spike Success.
SK Hynix is not just any chipmaker; it is the leading supplier of High Bandwidth Memory (HBM), essential for large-scale AI training. The company is ramping up production to meet the demands of NVIDIA’s upcoming Rubin platform, which relies on HBM4 technology. UBS forecasts that SK Hynix will achieve an operating profit of ₩32.7 trillion (approximately $21.4 billion) in 2026, increasing to ₩62.3 trillion (around $40.7 billion) in 2027.
The proceeds from the ADR offering are expected to be reinvested into acquiring new equipment and expanding chip fabrication facilities in Korea. Additionally, there is potential for share repurchases following the listing, which could further boost both ADR and common share prices.
By listing in New York, SK Hynix will gain access to US institutional capital, allowing funds focused on AI and semiconductor investments to allocate resources directly without the complexities of the Korean market, such as currency hedging and time zone differences.
The scale of this deal, potentially reaching $29 billion, positions it among the largest ADR offerings ever. UBS's recommendation to buy ADRs and sell Korean shares is based on an arbitrage strategy, betting that the ADRs will command a premium due to enhanced liquidity and accessibility for US institutional investors.
However, there are risks involved, particularly the cyclical nature of the memory chip market. While SK Hynix's current margins appear strong, the semiconductor industry has a history of overproduction during boom periods, leading to price declines. UBS’s optimistic outlook hinges on sustained AI demand to absorb the anticipated increase in production capacity.
The expected $3.5 billion in passive inflows serves as a short-term catalyst, but once these funds are absorbed, the ADR will need to rely on its underlying fundamentals for continued performance.




